Volume 5, Issue 3
Book Reviewp. 281
Future advances in pharmacogenomics: BAFF, APRIL and plasma cells
Author(s): A Davidson
Book Reviewp. 287
VEGF as an activity marker in rheumatoid arthritis
Author(s): Z Szekanecz & AE Koch
Perspective Articlep. 291
Assessment of multiple organ systems in systemic lupus erythematosus: what will the new guidelines mean?
Author(s): M Mosca, S Bombardieri & L Carmona
Review Articlep. 299
A new role for antimalarials in systemic lupus erythematosus treatment
Author(s): J-L Ayensa, M Khamashta & G Ruiz-Irastorza
Review Articlep. 313
Treatment adherence to diseasemodifying antirheumatic drugs in patients with rheumatoid arthritis and systemic lupus erythematosus
Author(s): S de Achaval & ME Suarez-Almazor
Review Articlep. 327
Cervical spondylotic myelopathy: surgical outcomes in the elderly
Author(s): DW Cadotte, A Karpova & MG Fehlings
Review Articlep. 339
Role of plasma exchange in the treatment of primary vasculitides
Author(s): AL Casian & DRW Jayne
Review Articlep. 355
Raynauds phenomenon and digital ischemia: a practical approach to risk stratification, diagnosis and management
Author(s): ZH McMahan & FM Wigley
Review Articlep. 371
Bone densitometry and true BMD accuracy for predicting fractures: what are the alternatives?
Author(s): H Sievanen
Editorialp. 269
Specificity versus sensitivity: how rheumatoid arthritis diagnosis has changed over the last 10 years
Author(s): MJ Leandro
Editorialp. 273
Exploring the link between depression and rheumatoid arthritis: prospects for optimal therapeutic success
Author(s): M Kojima, T Kojima, N Ishiguro & TA Furukawa
Brief Reportp. 277
New study indicates link between obesity and the development of fibromyalgia
Author(s): Bulletin Board
Brief Reportp. 278
Intravenous immunoglobulin shows potential as treatment for pain syndrome In brief
Author(s): Bulletin Board
Brief Reportp. 279
Identification of possible new genetic link to scleroderma
Author(s): Bulletin Board
